文献速递中毒与环境急症消化、代谢与肾脏急症

摄入含水杨酸甲酯的药油后血清水杨酸盐浓度的变化轨迹

The trajectory of serum salicylate concentrations after ingestion of medicinal oil containing methyl salicylate.
PubMed 文献 · Clin Toxicol (Phila) · 2024-10-10
一句话结论摄入含水杨酸甲酯药油后血清水杨酸盐浓度达峰中位时间为5.6小时,气道保护下数小时内可考虑胃吸引和单剂活性炭。

这项回顾性队列研究纳入2008年7月1日至2023年6月30日期间香港中毒控制中心报告的41例实验室确诊水杨酸甲酯中毒患者,分析至少3次血清水杨酸盐浓度。从摄入到首次峰浓度中位时间为5.6小时(IQR 3.2-10.8小时)。多变量回归显示,胃吸引(校正β -2.50;95%CI -3.93至-1.08;P=0.001)和单剂活性炭(校正β -1.22;95%CI -2.02至-0.42;P=0.003)与较低峰浓度显著相关。作者认为水杨酸盐浓度达峰并不像通常认为的那样快,强调持续监测的重要性;气道保护下摄入药油后数小时内可考虑胃吸引和单剂活性炭。

要点

  • 摄入含水杨酸甲酯药油后血清水杨酸盐浓度达峰中位时间为5.6小时(IQR 3.2-10.8小时),提示需持续监测。
  • 胃吸引与较低峰浓度显著相关(校正β -2.50;95%CI -3.93至-1.08;P=0.001)。
  • 单剂活性炭与较低峰浓度显著相关(校正β -1.22;95%CI -2.02至-0.42;P=0.003)。
  • 作者认为,气道保护下摄入药油后数小时内可考虑胃吸引和单剂活性炭。
  • 胃吸引和单剂活性炭对临床结局的影响仍不明确。

适用人群与场景

  • 2008年7月1日至2023年6月30日期间香港中毒控制中心报告的、由当地所有公立急诊科实验室确诊的水杨酸甲酯中毒连续患者。
  • 纳入至少3次血清水杨酸盐浓度测定的病例。

处置流程与药物剂量

  • 作者认为,气道保护下摄入药油后数小时内可考虑胃吸引和单剂活性炭。

研究设计与关键结果

  • 回顾性队列研究,纳入41例患者(中位年龄81.0岁;32例女性,9例男性)。
  • 从摄入到首次血清水杨酸盐峰浓度的中位时间为5.6小时(IQR 3.2-10.8小时)。
  • 多变量广义线性回归显示,校正患者年龄、性别、故意自伤暴露、报告摄入剂量、从摄入到急诊就诊时间、呕吐、同时使用阿司匹林(乙酰水杨酸)及其他影响胃排空或胃酸分泌的药物、血pH、血清白蛋白浓度和肌酐清除率后,胃吸引与较低峰浓度显著相关(校正回归系数β -2.50;95%CI -3.93至-1.08;P=0.001)。
  • 同一多变量模型显示,单剂活性炭与较低峰浓度显著相关(校正β -1.22;95%CI -2.02至-0.42;P=0.003)。
  • 讨论指出,胃吸引和单剂活性炭可能有助于减少胃肠道吸收,但其对临床结局的影响仍不明确。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,鉴于从摄入到血清水杨酸盐峰浓度的中位时间为5.6小时(IQR 3.2-10.8小时),气道保护下摄入药油后数小时内可考虑胃吸引和单剂活性炭。
  • 作者认为,血清水杨酸盐浓度达峰并不像通常认为的那样快,强调持续监测的重要性。
  • 胃吸引和单剂活性炭对临床结局的影响仍不明确。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The toxicokinetics of methyl salicylate after unintentional or intentional ingestion of medicinal oil containing methyl salicylate has not been well studied. We aimed to characterize the trajectory of serum salicylate concentrations and to evaluate factors associated with the peak serum salicylate concentration and the time from ingestion to peak concentration.

METHODS: This was a retrospective cohort study of consecutive patients reported to the Hong Kong Poison Control Centre for laboratory-confirmed methyl salicylate poisoning by all local public emergency departments between 1 July 2008 and 30 June 2023. We analyzed cases with at least three serum salicylate concentrations. Multivariable generalized linear regression was used to identify factors significantly associated with the peak serum concentration and the time from ingestion to peak concentration.

RESULTS: We included 41 patients (median age 81.0 years; 32 women and nine men). The median time from ingestion to the first peak serum salicylate concentration was 5.6 h (IQR: 3.2-10.8 h). Multiple regression showed that gastric aspiration (adjusted regression coefficient [β] - 2.50; 95% CI: -3.93 to -1.08; P = 0.001) and single-dose activated charcoal (adjusted β - 1.22; 95% CI: -2.02 to -0.42; P = 0.003) were significantly associated with a lower peak concentration, after adjusting for patient age, sex, exposure due to intentional self-harm, reported ingested dose, time from ingestion to emergency department presentation, vomiting, concurrent use of aspirin (acetylsalicylic acid) and other medications that affect gastric emptying or gastric acid secretion, blood pH, serum albumin concentration, and creatinine clearance.

DISCUSSION: The serum salicylate concentration did not peak as quickly as generally believed, highlighting the importance of continued monitoring. Gastric aspiration and single-dose activated charcoal may help reduce gastrointestinal absorption, but their impact on clinical outcomes remains unclear.

CONCLUSIONS: Given the median time of 5.6 h (IQR: 3.2-10.8 h) from ingestion to the peak salicylate concentration, gastric aspiration and single-dose activated charcoal can be considered in patients up to a few hours after medicinal oil ingestion when the airway is protected.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Lam RPK, Chan CK, Tse ML, et al. The trajectory of serum salicylate concentrations after ingestion of medicinal oil containing methyl salicylate. Clin Toxicol (Phila). 2024. PMID: 39387701. doi:10.1080/15563650.2024.2409826

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。